Disease relevance of PAFC

• BACKGROUND: In some patients passage of a pulmonary artery flotation catheter (PAFC) into the pulmonary artery may be difficult and time consuming and the prolonged manipulation can cause ventricular arrhythmias [1].

High impact information on PAFC

• PATIENTS: Thirty consecutive patients in severe circulatory shock who required insertion of a pulmonary artery flotation catheter (PAFC) immediately on intensive care unit admission [2].
• MEASUREMENTS AND MAIN RESULTS: Oxyhemoglobin saturation in the superior vena cava, right atrium, and pulmonary artery (SVO2) was measured by cooximetry in consecutive blood samples from each site during initial insertion of the PAFC [2].
• The platelet counts of patients with PAFC were studied prospectively, 45 patients admitted to the ICU during the same period of time, who did not require PAFC were used as a control group [3].
• On the other hand PAFC (Phosphoric Acid Fuel Cell) operates at a higher temperature and the platinum electrode oxidizes carbon monoxide poison while there is a leakage problem of the liquid phase [4].
• The properties of PAFSC in comparison with polyaluminum silicate chloride (PASC) and polyferric silicate chloride (PAFC) were characterized by various experimental methods [5].

Biological context of PAFC

• The zeta potential of PAFC hydrolysis products of PAFC and the coagulation performances under different pH value were discussed [6].

Associations of PAFC with chemical compounds

• Polyaluminium ferric chloride (PAFC), a new type of inorganic composite coagulant, was prepared by using the waste from the Mineral Bureau of Yanzhou, China, hydrochloric acid and calcium carbonate as raw materials [6].

Analytical, diagnostic and therapeutic context of PAFC

• We found a significant platelet decrease in the PAFC group at 6 h (p less than 0.001), 24 h (p less than 0.001), 48 h (p less than 0.001) and 72 h (p less than 0.001) after catheter placement, compared to the control group [3].

References